The detailed mechanisms underlying the higher plasma Aβ42/40 levels in patients with PD remain unknown, but one possible explanation is that alpha-synuclein uptake may interfere with monomeric Aβ40 [45]. The gene discussed is SNCA; the disease is Parkinson disease.